Literature DB >> 3584121

Serum lectin with known structure activates complement through the classical pathway.

K Ikeda, T Sannoh, N Kawasaki, T Kawasaki, I Yamashina.   

Abstract

Serum mannan-binding protein (MBP), a lectin specific for mannose and N-acetylglucosamine, was revealed to activate the complement system as measured by passive hemolysis using sheep erythrocytes coated with yeast mannan. In contrast, rat liver MBP, which shares many properties in common with serum MBP, could not activate complement at all. The activation by serum MBP was inhibited effectively by the presence of haptenic sugars and dependent absolutely upon the presence of C4, indicating that the activation is initiated by the sugar binding activity of MBP and proceeds through the classical pathway. The 25 NH2-terminal amino acid sequence of rat serum MBP determined in this study was completely matched with that of MBP-A deduced from cDNA sequence by Drickamer et al. (Drickamer, K., Dordal, M. S., and Reynolds, L. (1986) J. Biol. Chem. 261, 6878-6887), revealing that MBP-A is in fact identical with serum MBP. On the basis of the knowledge of primary structures and physicochemical properties of rat serum and liver MBPs, a possible mechanism of the complement activation by serum MBP is discussed with reference to close similarity in the gross structures of serum MBP and C1q.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584121

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  91 in total

Review 1.  The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung.

Authors:  Francis X McCormack; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Complement inhibition alleviates paraquat-induced acute lung injury.

Authors:  Shihui Sun; Hanbin Wang; Guangyu Zhao; Yingbo An; Yan Guo; Lanying Du; Hongbin Song; Fei Qiao; Hong Yu; Xiaohong Wu; Carl Atkinson; Shibo Jiang; Stephen Tomlinson; Yusen Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-18       Impact factor: 6.914

4.  Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man.

Authors:  R A Childs; K Drickamer; T Kawasaki; S Thiel; T Mizuochi; T Feizi
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

5.  Detection and characterization of natural and inducible lectins in human serum.

Authors:  Beulaja Manikandan; Manikandan Ramar
Journal:  Results Immunol       Date:  2012-06-07

6.  Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans.

Authors:  M Ohta; T Kawasaki
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

7.  A study of novel lectins and their involvement in the activation of the prophenoloxidase system in Blaberus discoidalis.

Authors:  C Chen; H J Durrant; R P Newton; N A Ratcliffe
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

Authors:  Michaela Windbichler; Bernd Echtenacher; Thomas Hehlgans; Jens C Jensenius; Wilhelm Schwaeble; Daniela N Männel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Recombinant bovine conglutinin, lacking the N-terminal and collagenous domains, has less conglutination activity but is able to inhibit haemagglutination by influenza A virus.

Authors:  S Eda; Y Suzuki; T Kase; T Kawai; K Ohtani; T Sakamoto; T Kurimura; N Wakamiya
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

10.  Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes.

Authors:  Peter Garred; Morten A Nielsen; Jørgen A L Kurtzhals; Rajneesh Malhotra; Hans O Madsen; Bamenla Q Goka; Bartholomew D Akanmori; Robert B Sim; Lars Hviid
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.